TG Therapeutics, Inc. (LON:0VGI)
London flag London · Delayed Price · Currency is GBP · Price in USD
37.50
-1.05 (-2.72%)
At close: Mar 14, 2025

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Novel Treatments for B-cell Diseases
329.00M
Log In
Log In
Log In
Log In
Novel Treatments for B-cell Diseases Growth
40.80%
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
United States
329.00M
Log In
Log In
Log In
Log In
United States Growth
40.80%
Log In
Log In
Log In
Log In